Advanced Hodgkin’s lymphoma: End-of-treatment FDG-PET should be maintained
Crossref DOI link: https://doi.org/10.1007/s00259-017-3714-4
Published Online: 2017-05-02
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hindié, Elif
Mesguich, Charles
Bouabdallah, Krimo
Milpied, Noël
License valid from 2017-05-02